VYGR at support for a day trade of 15+%VYGR at support for a day trade of 15+%
this TP2 should give a pullback for a long swing trade plan
1.34USD
−46.408MUSD
40.907MUSD
34.802M
About Voyager Therapeutics, Inc.
Sector
Industry
CEO
Alfred W. Sandrock
Website
Headquarters
Lexington
Employees (FY)
125
Founded
2013
ISIN
US92915B1061
Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang Ping Gao, Mark A. Kay, Krystof Bankiewicz, and Phillip Zamore in June 2013 and is headquartered in Lexington, MA.
Target $ 6.12Voyager Therapeutics (VYGR) has signed an agreement through which Pfizer Inc. (PFE) may exercise options to license novel capsids generated from Voyager's TRACER screening technology to treat certain neurologic and cardiovascular diseases.
Under terms of the deal, Pfizer will have the right to eval
VYGRVoyager Therapeutics Inc (NASDAQ:VYGR) broke above resistance in Friday's trading session after a small period of consolidation. I still like this stock and will be watching it again on Monday, expecting to see a continuation move.
8-to-1 Reward to Risk RatioSee my detailed trade on the chart. Enjoy!
Green = Profit target
Red = Stoploss
My position size is based on my risk tolerance given the stoploss level.
If you like my content, feel free to support my Pro membership by sending a "Cheer".
Big News, potential breakoutVoyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang Pin
Chart Play on VYGRRSI Reversing
MACD Cross on Daily
Descending Wedge
All time low, consolidtaing at this price
Swing on time
VYGR Breakout Stock Alert UpdateBREAKOUT STOCK ALERT UPDATE
$VYGR - Voyager Therapeutics, Inc. - Common Stock
Initial Alert Price: $8.38
Price High: $7.19
% Gains/Losses: -14.2%
(-29.63% Less Than Expected)
Potential Stop Loss: $6.8305
VYGR is currently trading below our 10% Sell Threshold but we have are watching to determine i
VYGR Technical Analysis 🧙Voyager Therapeutics Inc is functional in the United States biotechnology industry. Its focus lies in the research and development of gene therapies for the cure of severe diseases of the central nervous system such as the Parkinson's, Huntington's and Alzheimer's disease. The company has developed
voyager therapeutics could jump up on another surprise earningsVoyager therapeutics could jump up on another surprise earnings
The 50 day Moving average is below the 100 and 200 day moving - volume is up
and earnings have amazing earnings up 60% and 1300% these last few quarters so.... it might turn around - I am not buying at this price though.
How long can y
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
